Метиленовый синий: чудо-средство от рака, Альцгеймера, инфекций, боли и усталости за копейки?

Scientific Concepts, Discoveries, and Nature/Medical Phenomena Mentioned

Chemical origin and properties

• Methylene blue is described as a compound synthesized in 1876 by Heinrich Caro, originally for the textile dye industry.
• In later nature/food/clinical contexts, it is mentioned as a disinfection and indicator dye, including:
  • Aquarium water disinfection, attributed to antibacterial properties.
  • Assessing milk freshness/contamination:
    • Milk is said to remain blue if not contaminated.
    • It is said to change/revert if bacterial contamination occurs.

---

Blood chemistry: methemoglobin and hemoglobin redox conversion

Methemoglobin neutralization (treatment role)

• Hemoglobin carries oxygen via iron.
• In intoxication/drug overdose, iron may shift oxidation state and form methemoglobin (described as “honey hemoglobin”), leading to reduced oxygen delivery and a “suffocation” feeling.
• Methylene blue is described as a rapid antidote, converting Fe³⁺ (trivalent iron) → Fe²⁺ (divalent iron) to restore functional hemoglobin, potentially within minutes rather than hours.

---

Mitochondrial redox and cellular energy

Mitochondria-focused mechanism (claims in the text/video)

• Methylene blue is described as affecting the cell redox balance and acting as an electron donor for mitochondria.
• Claimed outcomes include:
  • Improved mitochondrial membrane electrical potential
  • Improved energy production
• These effects are linked to diseases purported to involve mitochondrial dysfunction, such as:
  • Chronic fatigue
  • Alzheimer’s disease
  • Cancer

---

Enzyme targets and neurotransmitter signaling

MAO-A inhibition (MAO blocker)

• Methylene blue is described as an MAO-A inhibitor.
• MAO-A breaks down biogenic amines such as serotonin.
• Claimed effects include:
  • Potential mood improvement
  • Potential enhancement of cognitive function, including memory and attention

Nitric oxide pathway inhibition

• The text claims methylene blue blocks an enzyme involved in nitric oxide (NO) production.
• Suggested implications include:
  • Vessel constriction (opposite of NO-driven vasodilation)
  • Relevance to septic/bacterial shock, where vascular tone may collapse
• Additional discussion: NO’s roles in cancer cell division, metastasis, and angiogenesis (new vessel formation).

---

Antibacterial/antiseptic use and infection-related analgesia

Urologic antiseptic/analgesic claim

• A previously used combination drug (“geophil” mentioned) containing methylene blue is said to treat acute cystitis.
• Proposed mechanism:
  • Methylene blue is excreted by the kidneys
  • It accumulates in the bladder
  • It exerts antiseptic/disinfectant and analgesic effects

---

Clinical trial examples and study types (as described)

• Chemotherapy-related stomatitis pain

  • Patients rinsed with methylene blue held in the mouth for ~5 minutes.
  • Reported outcome: reduced pain (graphs mentioned).

• Unexplained severe anal itching

  • Patients with severe itching received local injections around the area with methylene blue + lidocaine.
  • Follow-up claim: many reported no recurrence over 3 years.

• Spinal/pain management

  • Injection between vertebral discs with methylene blue reportedly reduced pain versus placebo.

• Alzheimer’s disease progression

  • Mentioned: a Phase 2, double-blind, placebo-controlled trial
    • 321 patients, referenced as 2015
    • Claimed benefit over ~6 months
  • Also stated: it is not yet part of official Alzheimer’s treatment protocols.

---

Preclinical and oncological concepts

Neurodegenerative “protein tangles”

• In preclinical studies (and “phase II” mentioned), methylene blue is reported to reduce formation of pathological protein tangles (described generally for Alzheimer’s/Parkinson’s), potentially slowing or stopping progression.

Cancer diagnostics: lymph node mapping (tracer use)

• In the described oncology use, methylene blue is used as a tracer:
  • Surgeons inject methylene blue near/into tumors.
  • It travels via lymphatics and stains sentinel/lymph nodes.
  • This improves detection and removal to evaluate metastasis.
• Examples mentioned:
  • Bowel cancer
  • Breast cancer

Photodynamic therapy (PDT) with methylene blue as a photosensitizer

• The text describes methylene blue as a photosensitizer used in photodynamic therapy:
  1. Administer methylene blue (into tumor or intravenously)
  2. Wait for differential accumulation/clearance in healthy vs. tumor tissue
  3. Apply light to the tumor region
  4. Light activation generates free radicals, damaging tumor cells
• Limitation noted: light penetration depth limits effectiveness for deep tumors.

Direct anticancer mechanisms (preclinical claims)

Claims attributed in the text/video include:

• Blocking cell division and metastasis, linked to nitric oxide pathway effects
• Reducing metastasis/angiogenesis via effects on mitochondria
• Improving energy metabolism
• Reducing lactic acid production
  • Linked to the “metabolic theory of cancer,” where tumors may rely on lactic acid for survival against radiation, chemotherapy, and immunity
• “Disarming” tumors resistant to chemo/radiation in preclinical settings, with emphasis on combination therapy rather than monotherapy

Potential shock treatment (septic/blood poisoning)

• The text mentions intravenous use/study in blood poisoning/septic shock, associated with vasoconstriction due to NO inhibition.
• It also discusses risk concerns: excessive spasm and blood pressure increases at higher doses.

---

Dose-dependent redox behavior and safety hazards

Antioxidant vs pro-oxidant (dose dependence)

• Low doses: described as acting as an antioxidant and supporting mitochondrial function.
• High doses: described as becoming pro-oxidant, producing free radical damage.
• Low-dose range stated: ~0.5 to 2 mg/kg, with “up to 4 mg/kg” cited.
• Safety/dosing uncertainty is noted due to limited clinical trials.

Genetic/hematologic risk

• G6PD deficiency: risk of hemolysis (“red blood cells burst”).
• Not allowed for newborns (risk to lungs/hemolysis mentioned).

Other side effects

• Vascular constriction → increased blood pressure
• Photosensitivity: avoid sunlight
• GI upset: nausea, vomiting, diarrhea
• Blue urine (expected)

Serotonin syndrome risk (MAO inhibition interactions)

• Because methylene blue is described as an MAO blocker, combining it with drugs that increase serotonin or affect MAO can cause serotonin syndrome.
• Listed symptoms:
  • Increased temperature
  • Tremors
  • Convulsions
  • Stomach pain
• Not recommended combinations mentioned:
  • Antidepressants
  • St. John’s wort
  • Passionflower
  • “Novopasit” (example mentioned)
• Additional interaction concerns from natural products/foods:
  • Turmeric, quercetin
  • Green tea, ginseng, Rhodiola rosea
  • Foods rich in tyramine (e.g., aged cheeses, dried meats) due to MAO-related interaction risk

Cancer/Alzheimer’s caution

• Conclusion stated in the text: methylene blue is not recommended as an official treatment for cancer or Alzheimer’s today, despite mention of “unofficial protocols.”

---

Methodology / treatment approaches outlined

Treatment/management concepts

• Methemoglobin reversal
  • Convert Fe³⁺ → Fe²⁺ using methylene blue as an antidote in certain intoxications/drug overdoses.
• Symptom-directed infection control
  • Bladder and mouth applications described for antibacterial/analgesic effects (cystitis; stomatitis rinses).
• Pain procedures
  • Oral rinses for chemotherapy stomatitis
  • Local perianal injections with methylene blue + lidocaine
  • Intradiscal/near-discal injections for spine-related pain

Photodynamic therapy (PDT) using methylene blue

• Steps described:
  • Inject methylene blue (tumor or intravenously)
  • Wait for differential accumulation/clearance
  • Shine targeted light on the tumor
  • Generate free radicals → tumor cell damage

Surgical oncology tracer technique

• Steps described:
  • Inject methylene blue near the tumor
  • It travels via lymphatics and stains lymph nodes
  • Surgeons identify/remove sentinel nodes to assess metastasis

---

Featured researchers / sources (named)

• Heinrich Caro — credited with synthesis of methylene blue in 1876
• Doctor Igor Igorevich Atabekov — speaker; oncologist